Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
N/A
This is a nationwide observational study looking at how ravulizumab, a comp...
Status
Not Yet Recruiting
Location
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens